Shane William Charles Kovacs, the CH. OPERATING & FINANCIAL OFF. of $OLMA, sold 3,822 shares of the company on 01-13-2026 for an estimated $107,054. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.6% of their shares of this class of stock. Following this trade, they now own 239,727 shares of this class of $OLMA stock.
$OLMA Insider Trading Activity
$OLMA insiders have traded $OLMA stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $OLMA stock by insiders over the last 6 months:
- IAN T CLARK has made 0 purchases and 3 sales selling 264,800 shares for an estimated $7,873,109.
- NASEEM ZOJWALLA (Chief Medical Officer) has made 0 purchases and 4 sales selling 269,509 shares for an estimated $7,530,147.
- DAVID C. MYLES (CH. DISCOV. & NON-CLIN DEV OFF) has made 0 purchases and 8 sales selling 161,000 shares for an estimated $4,660,772.
- SHANE WILLIAM CHARLES KOVACS (CH. OPERATING & FINANCIAL OFF.) has made 0 purchases and 2 sales selling 103,822 shares for an estimated $2,980,054.
- CYRUS HARMON has made 0 purchases and 5 sales selling 27,881 shares for an estimated $287,035.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OLMA Hedge Fund Activity
We have seen 59 institutional investors add shares of $OLMA stock to their portfolio, and 52 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MPM BIOIMPACT LLC removed 2,378,762 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $23,288,079
- WOODLINE PARTNERS LP removed 1,288,000 shares (-36.7%) from their portfolio in Q3 2025, for an estimated $12,609,519
- MILLENNIUM MANAGEMENT LLC removed 939,636 shares (-73.9%) from their portfolio in Q3 2025, for an estimated $9,199,036
- SILVERARC CAPITAL MANAGEMENT, LLC added 933,541 shares (+inf%) to their portfolio in Q3 2025, for an estimated $9,139,366
- KINGDON CAPITAL MANAGEMENT, L.L.C. added 854,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,360,659
- BALYASNY ASSET MANAGEMENT L.P. added 693,179 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,786,222
- SOLEUS CAPITAL MANAGEMENT, L.P. added 619,874 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,068,566
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OLMA Analyst Ratings
Wall Street analysts have issued reports on $OLMA in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 01/07/2026
- Piper Sandler issued a "Overweight" rating on 01/07/2026
- Citigroup issued a "Buy" rating on 12/12/2025
- Goldman Sachs issued a "Buy" rating on 11/21/2025
- JP Morgan issued a "Overweight" rating on 11/18/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/18/2025
- Oppenheimer issued a "Outperform" rating on 11/18/2025
To track analyst ratings and price targets for $OLMA, check out Quiver Quantitative's $OLMA forecast page.
$OLMA Price Targets
Multiple analysts have issued price targets for $OLMA recently. We have seen 7 analysts offer price targets for $OLMA in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Michael Yee from UBS set a target price of $45.0 on 01/07/2026
- Yigal Nochomovitz from Citigroup set a target price of $60.0 on 12/12/2025
- Matthew Biegler from Oppenheimer set a target price of $48.0 on 12/11/2025
- Richard Law from Goldman Sachs set a target price of $38.0 on 12/11/2025
- Emily Bodnar from HC Wainwright & Co. set a target price of $45.0 on 12/11/2025
- Anupam Rama from JP Morgan set a target price of $32.0 on 11/18/2025
- Brad Canino from Guggenheim set a target price of $20.0 on 10/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
